RU2012155738A - COMPOSITION OF ANTIOXIDANT COMPOSITION AIMED AT SUPPRESSING OXIDATIVE STRESS IN TYPE 2 DIABETES - Google Patents
COMPOSITION OF ANTIOXIDANT COMPOSITION AIMED AT SUPPRESSING OXIDATIVE STRESS IN TYPE 2 DIABETES Download PDFInfo
- Publication number
- RU2012155738A RU2012155738A RU2012155738/15A RU2012155738A RU2012155738A RU 2012155738 A RU2012155738 A RU 2012155738A RU 2012155738/15 A RU2012155738/15 A RU 2012155738/15A RU 2012155738 A RU2012155738 A RU 2012155738A RU 2012155738 A RU2012155738 A RU 2012155738A
- Authority
- RU
- Russia
- Prior art keywords
- composition
- diabetes
- type
- oxidative stress
- aimed
- Prior art date
Links
- 239000003963 antioxidant agent Substances 0.000 title claims abstract 5
- 230000003078 antioxidant effect Effects 0.000 title claims abstract 5
- 230000036542 oxidative stress Effects 0.000 title claims abstract 5
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title claims abstract 5
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims abstract 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims abstract 4
- 235000006708 antioxidants Nutrition 0.000 claims abstract 4
- 235000017471 coenzyme Q10 Nutrition 0.000 claims abstract 4
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims abstract 4
- 229940110767 coenzyme Q10 Drugs 0.000 claims abstract 4
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims abstract 4
- 229960003966 nicotinamide Drugs 0.000 claims abstract 2
- 235000005152 nicotinamide Nutrition 0.000 claims abstract 2
- 239000011570 nicotinamide Substances 0.000 claims abstract 2
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
1. Композиция антиоксидантного состава, направленного на подавление окислительного стресса при диабете 2 типа, содержащая в расчете на 1 дозу: коэнзим Q10 50-120 мг, дигидрокверцитин 30-160 мг, А-липоевую кислоту 30-60 мг.2. Композиция антиоксидантного состава, направленного на подавление окислительного стресса при диабете 2 типа, содержащая в расчете на 1 дозу: коэнзим Q10 50-100 мг, дигидрокверцитин 50-100 мг, А-липоевую кислоту 30-60 мг, никотинамид 50-100 мг.1. The composition of the antioxidant composition aimed at suppressing oxidative stress in type 2 diabetes, containing per dose: Coenzyme Q10 50-120 mg, dihydroquercytin 30-160 mg, A-lipoic acid 30-60 mg. 2. Composition of an antioxidant composition aimed at suppressing oxidative stress in type 2 diabetes, containing per dose: Coenzyme Q10 50-100 mg, dihydroquercytin 50-100 mg, A-lipoic acid 30-60 mg, nicotinamide 50-100 mg.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2012155738/15A RU2535069C2 (en) | 2012-12-21 | 2012-12-21 | Composition of antioxidant composition aimed at suppression of oxidative process in case of type 2 diabetes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2012155738/15A RU2535069C2 (en) | 2012-12-21 | 2012-12-21 | Composition of antioxidant composition aimed at suppression of oxidative process in case of type 2 diabetes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2012155738A true RU2012155738A (en) | 2014-06-27 |
| RU2535069C2 RU2535069C2 (en) | 2014-12-10 |
Family
ID=51215976
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2012155738/15A RU2535069C2 (en) | 2012-12-21 | 2012-12-21 | Composition of antioxidant composition aimed at suppression of oxidative process in case of type 2 diabetes |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2535069C2 (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2123350C1 (en) * | 1997-12-30 | 1998-12-20 | Борщев Александр Николаевич | Phytoconcentrate of curative-prophylactic effect for patients with diabetes mellitus |
| AU5142699A (en) * | 1998-07-31 | 2000-02-28 | Mount Sinai Hospital Corporation | Methods and compositions for increasing insulin sensitivity |
| US6277842B1 (en) * | 2000-10-17 | 2001-08-21 | James Alexander Carthron | Dietary supplemental method for fat and weight reduction |
| CN101982115A (en) * | 2010-10-14 | 2011-03-02 | 张丽娜 | Composite for preventing and curing diabetes chronic sugar poisoning |
-
2012
- 2012-12-21 RU RU2012155738/15A patent/RU2535069C2/en active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2535069C2 (en) | 2014-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2014039903A3 (en) | Stable aqueous formulations of adalimumab | |
| IL233200A0 (en) | Alpha-amino boronic acid derivatives, their preparation and pharmaceutical compositions containing them | |
| MX2014004725A (en) | Etanercept formulations stabilized with amino acids. | |
| PH12015500900A1 (en) | A stabilized pemetrexed formulation | |
| WO2012104007A3 (en) | 7-azaindole derivatives | |
| AU2012265219A8 (en) | Compounds containing hydrido-tricyano-borate anions | |
| PH12014501991B1 (en) | Phenicol antibacterials | |
| MX2019013776A (en) | Treatment of solid tumors using coenzyme q10. | |
| WO2013153000A3 (en) | Insulin formulations | |
| PH12014502856B1 (en) | Solid pharmaceutical preparation containing levothyroxine | |
| MX2013013649A (en) | Quinone compounds for treating ape1 mediated diseases. | |
| MX2014004920A (en) | Novel pyrazine derivatives. | |
| WO2014039533A3 (en) | Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin | |
| MX2012010520A (en) | Antioxidant composition for reducing oxidative stress ascribable to the treatment with hormonal contraceptive drugs. | |
| AU2013338098A8 (en) | Solid salt form of alpha-6-mPEG6-O-hydroxycodone as opioid agonists and uses thereof | |
| RU2012155738A (en) | COMPOSITION OF ANTIOXIDANT COMPOSITION AIMED AT SUPPRESSING OXIDATIVE STRESS IN TYPE 2 DIABETES | |
| MY187748A (en) | Compositions and method for maintaining/improving cognitive function | |
| MX2015008262A (en) | Novel use of canthaxanthin and 25-hydroxy vitamin d3. | |
| WO2014011680A3 (en) | Tetrahydro-isohumulone derivatives, methods of making and using | |
| MX360017B (en) | Flavor and fragrance formulation (iv). | |
| MY172749A (en) | Use of cell wall disrupted product of chlorella for reducing serum resistin level | |
| IN2015DN02660A (en) | ||
| MX360531B (en) | Flavor and fragrance formulation (ii). | |
| MX2014004742A (en) | Novel phenicol antibacterials. | |
| UA92872C2 (en) | combined antiaggregate and antioxidant drug |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HE9A | Changing address for correspondence with an applicant |